申请人:Burns John Christopher
公开号:US20050004140A1
公开(公告)日:2005-01-06
A compound of the general formula:
or pharmaceutically acceptable salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating protein kinase-associated disease states using the compound of formula I is also described.
描述了一种具有以下一般式的化合物:或其药学上可接受的盐、水合物、溶剂合物、晶体形式或对映体。还描述了使用I式化合物治疗蛋白激酶相关疾病状态的方法。